Analysis reveals advances in immunotherapy strategies for glioblastoma, highlighting immune suppression challenges.
The analysis of 2,064 publications on GBM immunotherapy highlights a high level of collaborative effort aimed at advancing novel therapeutic approaches. The findings emphasize the importance of the tumor microenvironment and suggest that future efforts should focus on overcoming immune suppression and developing targeted combination therapies. This study provides a useful reference for guiding research and improving immunotherapy strategies in GBM.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: